PFIZER INC. for PFIZER INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2025 | $2,730,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 23, 2026 | $2,810,000 | Replaced |
| 3rd Quarter - Amendment | Mar 12, 2026 | $2,870,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCISCO CARRILLO | — |
| EMILY MUELLER | — |
| CATHERINE ROBINSON | — |
| MATTHEW STROIA | — |
| JENNIFER SWENSON WALTON | — |
| ANGELA BOOTHE WILES | — |
Medicare/Medicaid MMM
Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCISCO CARRILLO | — |
| EMILY MUELLER | — |
| ANGELA BOOTHE WILES | — |
Trade (domestic/foreign) TRD
International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISSA ALBEN | — |
| STEPHEN CLAEYS | — |
| EMILY MUELLER | — |
| CATHERINE ROBINSON | — |
| MATTHEW STROIA | — |
| JENNIFER SWENSON WALTON | — |
| ANGELA BOOTHE WILES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.